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ABSTRACT
Cardiovascular manifestations in hyperthyroidism occur frequently with various phenotypes. An association between hy-
perthyroidism and pulmonary arterial hypertension has been reported. In previously reported cases, the hemodynamic and 
symptomatic recovery of pulmonary arterial hypertension is usually concomitant with achievement of euthyroidism. We report 
a patient who had pulmonary arterial hypertension associated with Graves’ disease, which persisted after euthyroidism was 
obtained. (Korean Circ J 2010;40:593-595)
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Introduction 
Cardiovascular manifestations in hyperthyroidism occur 
frequently with various phenotypes. These include sinus ta-
chycardia, atrial fibrillation, dilated cardiomyopathy, and high-
output congestive heart failure.
1) Recent studies have suggest-
ed a possible association between hyperthyroidism and pul-
monary arterial hypertension.
2-4) Although the exact mechan-
ism of this combination has not yet been established, it has 
been hypothesized that thyroid hormones and autoimmuni-
ty have an important influence.
5) 
In the literature, the hemodynamic and symptomatic recov-
ery of pulmonary arterial hypertension is usually concomitant 
with achievement of euthyroidism.
5-8) We report a case of a pa-
tient who had persistent pulmonary arterial hypertension 
associated with Graves’ disease. Although clinical and bioche-
mical euthyroidism was attained within 1 month after the start 
of treatment, there was no improvement in right ventricular 
failure and echocardiographic pulmonary arterial hypertension. 
Case
A 48-year-old woman presented at our institution on June 
10, 2009 with a 4-week history of dyspnea on exertion, fatigue, 
hot flushes, palpitations, generalized edema, and weight gain. 
She had a history of hyperthyroidism (3 years ago), but had 
not pursued follow-up. She denied any prior history of effort-
induced dyspnea or chest discomfort before the diagnosis of 
thyroid disease was made. On physical examination, raised ju-
gular venous pressure, a slightly enlarged thyroid gland, and 
marked lower limb edema were observed. There was no audi-
ble heart murmur. Chest radiography showed mild cardio-
megaly with prominent pulmonary conus (Fig. 1). Electrocar-
diogram showed sinus rhythm at 100 beats per minute. She 
underwent transthoracic echocardiogram, which revealed a di-
lated right ventricle, reduced right ventricular systolic function, 
and an elevated systolic pulmonary arterial pressure over 57 
mmHg. The left ventricular chamber size was normal with an 
ejection fraction of 65%, and the valves appeared normal. Trans-
esophageal echocardiogram revealed no intracardiac shunts. 
Computed tomographic scanning of the chest did not reveal 
any evidence of parenchymal lung disease or pulmonary throm-
boembolism. A ventilation-perfusion scan of the chest showed 
that pulmonary embolism was unlikely. Pulmonary function 
test (FEV1/FVC=87.2%) revealed no evidence of chronic ob-594   Persistent Pulmonary Hypertension in Hyperthyroidism
structive lung disease. Thyroid function tests showed a decre-
ased serum thyroid-stimulating hormone (TSH) level of 0.06 
uIU/mL (normal, 0-4 uIU/mL), an increased serum free thy-
roxin (FT4) level of 2.91 ng/dL (normal, 0.8-2.2 ng/dL). Anti-
thyroperoxidase antibody was 404.97 IU/mL (nonreactive, 0- 
50 IU/mL) and TSH-receptor antibody was >404 U/I (nor-
mal, 0-14 U/l). Thyroid scan showed diffuse increased uptake 
suggestive of Graves’ disease. A set of anti-nuclear antibody test 
which includes 13 antibodies against various component of 
nucleus was negative. We started treating the patient with me-
thimazole (30 mg/day) and furosemide. 
The patient was followed up clinically and went through 
repeated thyroid function tests and transthoracic Doppler echo-
cardiography to determine pulmonary arterial pressure. Titra-
tion of methimazole dose continued, as well as monitoring by 
thyroid function tests and regular echocardiography. About 
1 month after initiation of treatment, the patient became both 
clinically and biochemically euthyroid (Table 1), but echocar-
diography revealed no reduction in pulmonary artery pres-
sure. Four months after therapy was initiated, we performed 
transthoracic echocardiography again but the pulmonary ar-
terial pressure remained over 57 mmHg (Fig. 2). 
Discussion 
The effects of thyroid hormones on myocardium and vas-
cular system are well known, but the mechanisms underly-
ing pulmonary arterial hypertension associated with hyper-
thyroidism have not been clearly identified. Possible mechan-
isms include direct effects of thyroid hormone and immune-
mediated endothelial damage and/or dysfunction.
5) The pre-
sent patient had severe pulmonary arterial hypertension with 
clinical signs of right ventricular failure. The normal left ven-
tricular function on echocardiography suggested that the pul-
monary hypertension was not due to left-sided or high-out-
put cardiac failure, and chronic pulmonary thromboembo-
lism was excluded by chest CT and perfusion lung scan. The 
pulmonary function test showed no evidence of chronic ob-
structive lung disease. On physical examination, there was no 
severe goiter or proptosis, but thyroid function tests were com-
patible with Graves’ disease. The possibility of autoimmune 
disease, which can also present with thyroid abnormalities and 
pulmonary hypertension, was considered negligible due to the 
negative result of the anti-nuclear antibody screening test. Thus, 
hyperthyroidism was thought to be the most likely etiology. 
The successful treatment of Graves’ disease leading to im-
Table 1. Change in thyroid function tests following treatment for hy-
perthyroidism in a patient with pulmonary hypertension
  At presentation 1 month later  
TSH (uIU/mL) 0.03 0.42 (0.4-4)
FT4 (ng/dL) 6.99 1.87 (0.8-2.2)
T3 (ng/dL) >781 146.23 (80-197)
TSH-R Ab (U/L) 240.17 333.22 (0-14)
TSH: thyroid-stimulating hormone, FT4: free thyroxin, TSH-R Ab: thy-
roid-stimulating hormone-receptor antibody
Fig. 1. Chest radiograph on admission shows mild cardiomegaly 
with prominent pulmonary conus.
A   B  
Fig. 2. Transthoracic echocardiography showing pulmonary artery pressure before (A) and after (B) treatment of hyperthyroidism.
*Vel 303 cm/s
*PG 37 mmHg
*Vel 282 cm/s
*PG 32 mmHgJin Yeon Hwang, et al.   595
provement in pulmonary arterial pressures has been previ-
ously reported with hemodynamic and symptomatic recov-
ery usually obtained concomitantly with achievement of euth-
yroidism.
5-8) A long time gap between achieving euthyroi-
dism and normalization of systolic pulmonary arterial pressure 
has rarely been reported.
9) The present patient was followed up 
clinically and with repeated transthoracic echocardiography 
and thyroid function tests. The clinical and biochemical eu-
thyroidism was achieved within 1 month of initial therapy, but 
there was no improvement in right ventricular failure and 
echocardiographic pulmonary arterial hypertension after four 
months. It is conceivable that the recovery time to normal-
ization of pulmonary artery pressure in this patient is just lon-
ger than those of most previous reports. Alternatively, this pa-
tient may represent refractory pulmonary arterial hyperten-
sion with partial irreversible structural change due to long-
standing hyperthyroid state. 
A significant percentage of patients with pulmonary arte-
rial hypertension have concomitant thyroid dysfunction, ei-
ther hyperthyroidism or hypothyroidism.
2-4) Treatment of pul-
monary arterial hypertension associated with hyperthyroidism 
primarily depends on the control of the thyrotoxic state. Thy-
roid function abnormalities should be considered in the in-
vestigation of every patient with unexplained systolic pulmo-
nary arterial hypertension, even with normal physical examin-
ation findings. Delayed recognition and treatment of hyper-
thyroidism might lead to refractory pulmonary arterial hyper-
tension as in the present case. 
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